Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Moseley Investment Management Inc.

Moseley Investment Management Inc. lessened its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 3.1% during the 4th quarter, HoldingsChannel.com reports. The firm owned 2,923 shares of the biotechnology company’s stock after selling 93 shares during the period. Moseley Investment Management Inc.’s holdings in Axon Enterprise were worth $1,737,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Public Sector Pension Investment Board raised its holdings in Axon Enterprise by 19.2% in the 3rd quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after buying an additional 500 shares during the period. CIBC Asset Management Inc increased its position in shares of Axon Enterprise by 9.2% during the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after acquiring an additional 895 shares during the last quarter. Foundations Investment Advisors LLC acquired a new stake in shares of Axon Enterprise during the third quarter valued at about $221,000. Sequoia Financial Advisors LLC raised its stake in shares of Axon Enterprise by 4.9% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock valued at $690,000 after acquiring an additional 81 shares during the period. Finally, Axxcess Wealth Management LLC purchased a new position in shares of Axon Enterprise during the 3rd quarter worth approximately $814,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Axon Enterprise Stock Up 2.0 %

Shares of Axon Enterprise stock opened at $579.80 on Wednesday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 52-week low of $246.99 and a 52-week high of $698.67. The company has a market capitalization of $44.21 billion, a P/E ratio of 149.82, a P/E/G ratio of 14.19 and a beta of 1.04. The company has a 50 day moving average of $610.03 and a 200 day moving average of $452.93.

Wall Street Analysts Forecast Growth

AXON has been the topic of a number of research analyst reports. JMP Securities boosted their target price on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research report on Thursday, October 31st. Northland Securities boosted their price objective on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Robert W. Baird increased their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. The Goldman Sachs Group lifted their target price on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Finally, Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. One research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $504.92.

Insider Activity

In related news, insider Jeffrey C. Kunins sold 21,834 shares of the company’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total value of $12,966,775.92. Following the completion of the transaction, the insider now directly owns 154,394 shares of the company’s stock, valued at $91,691,508.72. This represents a 12.39 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 50,545 shares of company stock worth $30,721,337. 6.10% of the stock is currently owned by corporate insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.